Asiatic Laboratories Limited (DSE:ASIATICLAB)
120.70
-3.40 (-2.74%)
At close: Jun 16, 2026
Asiatic Laboratories Revenue
Asiatic Laboratories had revenue of 788.96M BDT in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 2.90B. In the fiscal year ending June 30, 2025, Asiatic Laboratories had annual revenue of 1.77B with 27.45% growth.
Revenue (ttm)
2.90B
Revenue Growth
+27.45%
P/S Ratio
5.09
Revenue / Employee
3.94M
Employees
737
Market Cap
14.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.77B | 380.24M | 27.45% |
| Jun 30, 2024 | 1.39B | 95.98M | 7.44% |
| Jun 30, 2023 | 1.29B | -183.53M | -12.46% |
| Jun 30, 2022 | 1.47B | 21.53M | 1.48% |
| Jun 30, 2021 | 1.45B | 124.89M | 9.42% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Beximco Pharmaceuticals PLC. | 46.34B |
| Renata | 44.93B |
| The ACME Laboratories | 40.05B |
| Beacon Pharmaceuticals | 14.78B |
| The IBN SINA Pharmaceutical Industry | 13.48B |
| Navana Pharmaceuticals | 10.57B |
| Unilever Consumer Care | 3.49B |
| Techno Drugs | 3.10B |